Analyst Coverage Table
|
FIRM
|
ANALYST
|
|
BofA Securities, Inc.
|
Jason Gerberry
|
|
Barclays
|
Gena Wang
|
|
BMO Capital Markets
|
Kostas Biliouris
|
|
Canaccord
|
Whitney Ijem
|
|
Cantor Fitzgerald
|
Olivia Brayer
|
|
Citigroup
|
David Lebowitz
|
|
Evercore ISI
|
Cory Kasimov
|
|
Goldman Sachs
|
Salveen Richter
|
|
Guggenheim
|
Debjit Chattopadhyay
|
|
Jefferies
|
Akash Tewari
|
|
JP Morgan
|
Jessica Fye
|
|
Leerink Partners
|
Joseph Schwartz
|
|
Morgan Stanley
|
Vikram Purohit
|
|
Oppenheimer
|
Leland Gershell
|
|
Piper Sandler
|
Christopher Raymond
|
|
Raymond James
|
Danielle Brill
|
|
RBC
|
Luca Issi
|
|
RW Baird
|
Jack Allen
|
|
Scotia Capital (USA) Inc.
|
George Farmer, PhD
|
|
Stifel
|
Paul Matteis
|
|
TD Cowen
|
Philip Nadeau
|
|
Truist Securities
|
Joon Lee
|
|
UBS
|
Eliana Merle
|
|
Wedbush
|
Yun Zhong
|
|
Wells Fargo Securities, LLC
|
Mohit Bansal
|
|
William Blair & Company
|
Sami Corwin
|
|
Wolfe Research
|
Alexandria Hammond
|
Please note that any opinions, estimates or forecasts regarding
BioMarin Pharmaceutical Inc.'s performance made by these analysts
are theirs alone and do not represent opinions, forecasts or
predictions of BioMarin Pharmaceutical Inc. or its management.
BioMarin Pharmaceutical Inc. does not by its reference above or
distribution imply its endorsement of or concurrence with such
information, conclusions or recommendations.